After hours: January 10 at 5:56:11 PM EST Loading Chart for VNRX ...

Geode Capital Management LLC boosted its stake in shares of VolitionRx Limited (NYSE:VNRX – Free Report) by 15.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 730,448 shares of the ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced that it has retained LifeSci Advisors, LLC ("LSA") a premiere life sciences ...

VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0 ...

Highlights,VolitionRx focuses on epigenetics to aid in early cancer and disease detection.,Company’s market cap stands at $56 ...

At close: January 3 at 4:00:00 PM EST ...

内华达州亨德森 - 目前股价为每股0.64美元的跨国表观遗传学公司VolitionRx Limited (NYSE AMERICAN: VNRX)在其2024年业务回顾中报告了过去一年的主要成就。根据 InvestingPro 的数据，该公司在过去十二个月内实现了97.5%的可观收入增长，尽管分析师指出预计今年该公司不会盈利。公司已将其Nu.Q® ...

Pre-market: 8:30:23 am GMT-5 ...

HENDERSON, Nev. - VolitionRx Limited (NYSE AMERICAN: VNRX), a multi-national epigenetics company trading at $0.64 per share, has reported its key achievements from the past year in a Business Review ...